Tumor Vasculature

[1]  H. Dai,et al.  In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. , 2020, Nature nanotechnology.

[2]  F. Pfeiffer,et al.  Imaging characteristics of intravascular spherical contrast agents for grating-based x-ray dark-field imaging – effects of concentrations, spherical sizes and applied voltage , 2020, Scientific Reports.

[3]  P. Withers,et al.  X-ray computed tomography in life sciences , 2020, BMC Biology.

[4]  V. Pike,et al.  [11C]Carbon monoxide: advances in production and application to PET radiotracer development over the past 15 years , 2019, EJNMMI Radiopharmacy and Chemistry.

[5]  Daniel Razansky,et al.  Volumetric Multispectral Optoacoustic Tomography for 3-Dimensional Reconstruction of Skin Tumors: A Further Evaluation with Histopathologic Correlation. , 2019, The Journal of investigative dermatology.

[6]  Vasilis Ntziachristos,et al.  Use of Multispectral Optoacoustic Tomography to Diagnose Vascular Malformations , 2018, JAMA dermatology.

[7]  L. Claesson‐Welsh,et al.  Radionuclide imaging of VEGFR2 in glioma vasculature using biparatopic affibody conjugate: proof-of-principle in a murine model , 2018, Theranostics.

[8]  Chao Tian,et al.  Photoacoustic tomography for human musculoskeletal imaging and inflammatory arthritis detection , 2018, Photoacoustics.

[9]  Vasilis Ntziachristos,et al.  Multispectral optoacoustic tomography of systemic sclerosis , 2018, Journal of biophotonics.

[10]  T. Honda,et al.  Photoacoustic imaging system visualizes restoration of peripheral oxygenation in psoriatic lesions , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[11]  Michael Salamon,et al.  3D Imaging and Quantitative Analysis of Vascular Networks: A Comparison of Ultramicroscopy and Micro-Computed Tomography , 2018, Theranostics.

[12]  Vasilis Ntziachristos,et al.  Non-invasive Measurement of Brown Fat Metabolism Based on Optoacoustic Imaging of Hemoglobin Gradients. , 2018, Cell metabolism.

[13]  Franz Pfeiffer,et al.  Depiction of pneumothoraces in a large animal model using x-ray dark-field radiography , 2018, Scientific Reports.

[14]  E. Rummeny,et al.  Multispectral Optoacoustic Tomography (MSOT) of Human Breast Cancer , 2017, Clinical Cancer Research.

[15]  Franz Pfeiffer,et al.  Dark-field imaging in coronary atherosclerosis. , 2017, European journal of radiology.

[16]  G. Rubini,et al.  Multimodality Imaging in Tumor Angiogenesis: Present Status and Perspectives , 2017, International journal of molecular sciences.

[17]  F. Pfeiffer,et al.  Qualitative and Quantitative Evaluation of Structural Myocardial Alterations by Grating-Based Phase-Contrast Computed Tomography , 2017, Investigative radiology.

[18]  J. Hubbell,et al.  Local induction of lymphangiogenesis with engineered fibrin-binding VEGF-C promotes wound healing by increasing immune cell trafficking and matrix remodeling. , 2017, Biomaterials.

[19]  Wen-jie Ji,et al.  VEGF-C-mediated cardiac lymphangiogenesis in high salt intake accelerated progression of left ventricular remodeling in spontaneously hypertensive rats , 2017, Clinical and experimental hypertension.

[20]  Jie Liu,et al.  Novel small peptides derived from VEGF125-136: potential drugs for radioactive diagnosis and therapy in A549 tumor-bearing nude mice , 2017, Scientific Reports.

[21]  Lei Shi,et al.  VEGFR-2 inhibitors and the therapeutic applications thereof: a patent review (2012-2016) , 2017, Expert opinion on therapeutic patents.

[22]  Shaker A. Mousa,et al.  The Role of Angiogenesis in Cancer Treatment , 2017, Biomedicines.

[23]  V. Ntziachristos,et al.  Imaging of fatty tumors: appearance of subcutaneous lipomas in optoacoustic images , 2017, Journal of biophotonics.

[24]  V. Ntziachristos,et al.  Precision assessment of label-free psoriasis biomarkers with ultra-broadband optoacoustic mesoscopy , 2017, Nature Biomedical Engineering.

[25]  F. Pfeiffer,et al.  Qualitative and Quantitative Imaging Evaluation of Renal Cell Carcinoma Subtypes with Grating-based X-ray Phase-contrast CT , 2017, Scientific Reports.

[26]  A. Griffioen,et al.  Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy? , 2017, Angiogenesis.

[27]  Wolfgang Uter,et al.  Multispectral Optoacoustic Tomography for Assessment of Crohn's Disease Activity. , 2017, The New England journal of medicine.

[28]  N. Mochizuki,et al.  Carbohydrate-binding protein CLEC14A regulates VEGFR-2– and VEGFR-3–dependent signals during angiogenesis and lymphangiogenesis , 2016, The Journal of clinical investigation.

[29]  Elizabeth B. Herbst,et al.  Ultra–Low-Dose Ultrasound Molecular Imaging for the Detection of Angiogenesis in a Mouse Murine Tumor Model: How Little Can We See? , 2016, Investigative radiology.

[30]  Franz Pfeiffer,et al.  Facilitated Diagnosis of Pneumothoraces in Newborn Mice Using X-ray Dark-Field Radiography , 2016, Investigative radiology.

[31]  Peng Miao,et al.  Synchrotron Radiation X-Ray Phase-Contrast Tomography Visualizes Microvasculature Changes in Mice Brains after Ischemic Injury , 2016, Neural plasticity.

[32]  M. Schwaiger,et al.  In vivo biokinetic and metabolic characterization of the 68Ga-labelled α5β1-selective peptidomimetic FR366 , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[33]  J. Zhao,et al.  Promoting inflammatory lymphangiogenesis by vascular endothelial growth factor-C (VEGF-C) aggravated intestinal inflammation in mice with experimental acute colitis , 2016, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[34]  Daniel Razansky,et al.  Structural and Functional Analysis of Intact Hair Follicles and Pilosebaceous Units by Volumetric Multispectral Optoacoustic Tomography. , 2016, The Journal of investigative dermatology.

[35]  H. Kessler,et al.  Complementary, Selective PET Imaging of Integrin Subtypes α5β1 and αvβ3 Using 68Ga-Aquibeprin and 68Ga-Avebetrin , 2016, The Journal of Nuclear Medicine.

[36]  J. Zhuang,et al.  IL-6 mediates the signal pathway of JAK-STAT3-VEGF-C promoting growth, invasion and lymphangiogenesis in gastric cancer. , 2016, Oncology reports.

[37]  J. Klode,et al.  Photoacoustic imaging of real-time oxygen changes in chronic leg ulcers after topical application of a haemoglobin spray: a pilot study. , 2016, Journal of wound care.

[38]  Dirk Schadendorf,et al.  Metastatic status of sentinel lymph nodes in melanoma determined noninvasively with multispectral optoacoustic imaging , 2015, Science Translational Medicine.

[39]  A. Skálová,et al.  Expression of VEGF-C/-D and lymphangiogenesis in salivary adenoid cystic carcinoma. , 2015, Pathology, research and practice.

[40]  T. P. Millard,et al.  Evaluation of microbubble contrast agents for dynamic imaging with x-ray phase contrast , 2015, Scientific Reports.

[41]  Vasilis Ntziachristos,et al.  Advances in real-time multispectral optoacoustic imaging and its applications , 2015, Nature Photonics.

[42]  Edward Z. Zhang,et al.  Deep in vivo photoacoustic imaging of mammalian tissues using a tyrosinase-based genetic reporter , 2015, Nature Photonics.

[43]  A. Michalska,et al.  Lymphangiogenesis in cervical cancer evaluated by expression of the VEGF-C gene in clinical stage IB-IIIB , 2015, Przeglad menopauzalny = Menopause review.

[44]  H. Hollema,et al.  89Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment , 2015, The Journal of Nuclear Medicine.

[45]  Vasilis Ntziachristos,et al.  Broadband mesoscopic optoacoustic tomography reveals skin layers. , 2014, Optics letters.

[46]  S. Lassmann,et al.  Does Imaging αvβ3 Integrin Expression with PET Detect Changes in Angiogenesis During Bevacizumab Therapy? , 2014, The Journal of Nuclear Medicine.

[47]  Pieter Kruizinga,et al.  Photoacoustic imaging of carotid artery atherosclerosis , 2014, Journal of biomedical optics.

[48]  I. Eder,et al.  H-CRRETAWAC-OH, a Lead Structure for the Development of Radiotracer Targeting Integrin α 5 β 1? , 2014, BioMed research international.

[49]  Jolanda M Schwarz,et al.  X-Ray Phase-Contrast Tomography of Renal Ischemia-Reperfusion Damage , 2014, PloS one.

[50]  H. Ji,et al.  TNFR1 mediates TNF-α-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signalling , 2014, Nature Communications.

[51]  Emmanuel Brun,et al.  Cartilage and Soft Tissue Imaging Using X-rays: Propagation-Based Phase-Contrast Computed Tomography of the Human Knee in Comparison With Clinical Imaging Techniques and Histology , 2014, Investigative radiology.

[52]  Xiaoyuan Chen,et al.  68Ga-PRGD2 PET/CT in the Evaluation of Glioma: A Prospective Study , 2014, Molecular pharmaceutics.

[53]  E. Mittra,et al.  (18)F-FPPRGD2 PET/CT: pilot phase evaluation of breast cancer patients. , 2014, Radiology.

[54]  Vasilis Ntziachristos,et al.  Frequency domain optoacoustic tomography using amplitude and phase , 2014, Photoacoustics.

[55]  O. Prante,et al.  PET Radiopharmaceuticals for Imaging Integrin Expression: Tracers in Clinical Studies and Recent Developments , 2014, BioMed research international.

[56]  C. Meares,et al.  Development of a Radiolabeled Irreversible Peptide Ligand for PET Imaging of Vascular Endothelial Growth Factor , 2014, The Journal of Nuclear Medicine.

[57]  Nataly Wieberneit,et al.  A Study on Mastectomy Samples to Evaluate Breast Imaging Quality and Potential Clinical Relevance of Differential Phase Contrast Mammography , 2014, Investigative radiology.

[58]  R. Müller,et al.  A Novel In Vivo Vascular Imaging Approach for Hierarchical Quantification of Vasculature Using Contrast Enhanced Micro-Computed Tomography , 2014, PloS one.

[59]  F. Pfeiffer,et al.  Imaging Liver Lesions Using Grating-Based Phase-Contrast Computed Tomography with Bi-Lateral Filter Post-Processing , 2014, PloS one.

[60]  Xosé Luís Deán-Ben,et al.  Functional optoacoustic human angiography with handheld video rate three dimensional scanner☆ , 2013, Photoacoustics.

[61]  Franz Pfeiffer,et al.  Pulmonary emphysema diagnosis with a preclinical small-animal X-ray dark-field scatter-contrast scanner. , 2013, Radiology.

[62]  M. Schwaiger,et al.  Selective imaging of the angiogenic relevant integrins α5β1 and αvβ3. , 2013, Angewandte Chemie.

[63]  Franz Pfeiffer,et al.  Evaluation of phase-contrast CT of breast tissue at conventional X-ray sources - presentation of selected findings. , 2013, Zeitschrift fur medizinische Physik.

[64]  Franz Pfeiffer,et al.  Evaluation of the potential of phase-contrast computed tomography for improved visualization of cancerous human liver tissue. , 2013, Zeitschrift fur medizinische Physik.

[65]  M. Lerner,et al.  Molecular MRI differentiation of VEGF receptor-2 levels in C6 and RG2 glioma models. , 2013, American journal of nuclear medicine and molecular imaging.

[66]  W. Chan,et al.  Detection of lymphangiogenesis by near‐infrared fluorescence imaging and responses to VEGF‐C during healing in a mouse full‐dermis thickness wound model , 2013, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[67]  Françoise Peyrin,et al.  Synchrotron Radiation X-Ray Phase Micro-computed Tomography as a New Method to Detect Iron Oxide Nanoparticles in the Brain , 2013, Molecular Imaging and Biology.

[68]  F. Pfeiffer,et al.  Microbubbles as a scattering contrast agent for grating-based x-ray dark-field imaging , 2013, Physics in medicine and biology.

[69]  Vasilis Ntziachristos,et al.  Vaccinia virus-mediated melanin production allows MR and optoacoustic deep tissue imaging and laser-induced thermotherapy of cancer , 2013, Proceedings of the National Academy of Sciences.

[70]  Franz Pfeiffer,et al.  Assessment of grating-based X-ray phase-contrast CT for differentiation of invasive ductal carcinoma and ductal carcinoma in situ in an experimental ex vivo set-up , 2013, European Radiology.

[71]  Paola Coan,et al.  X-ray phase-contrast imaging: from pre-clinical applications towards clinics , 2013, Physics in medicine and biology.

[72]  Vasilis Ntziachristos,et al.  In vivo frequency domain optoacoustic tomography. , 2012, Optics letters.

[73]  B. R. Pinzer,et al.  Imaging brain amyloid deposition using grating-based differential phase contrast tomography , 2012, NeuroImage.

[74]  R. Pleijhuis,et al.  89Zr-Bevacizumab PET Imaging in Primary Breast Cancer , 2012, The Journal of Nuclear Medicine.

[75]  Lihong V. Wang,et al.  Photoacoustic Tomography: In Vivo Imaging from Organelles to Organs , 2012, Science.

[76]  D. Lee,et al.  Whole-body distribution and radiation dosimetry of (68)Ga-NOTA-RGD, a positron emission tomography agent for angiogenesis imaging. , 2012, Cancer biotherapy & radiopharmaceuticals.

[77]  Rhona A. Berganos,et al.  First Experience with Clinical-Grade [18F]FPP(RGD)2: An Automated Multi-step Radiosynthesis for Clinical PET Studies , 2012, Molecular Imaging and Biology.

[78]  M. Lubberink,et al.  Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs. , 2012, Cancer cell.

[79]  P. Beard.  Biomedical photoacoustic imaging , 2011, Interface Focus.

[80]  Judith E. Flores,et al.  The development of peptide-based tools for the analysis of angiogenesis. , 2011, Chemistry & biology.

[81]  P. Bruzzi,et al.  Vatalanib in advanced colorectal cancer: two studies with identical results. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[82]  P. Carmeliet,et al.  Molecular mechanisms and clinical applications of angiogenesis , 2011, Nature.

[83]  Kumar Sharma,et al.  Ultrasound Molecular Imaging of Tumor Angiogenesis With an Integrin Targeted Microbubble Contrast Agent , 2011, Investigative radiology.

[84]  Lihong V. Wang,et al.  In vivo functional photoacoustic microscopy of cutaneous microvasculature in human skin. , 2011, Journal of biomedical optics.

[85]  H. Hollema,et al.  VEGF-SPECT with ¹¹¹In-bevacizumab in stage III/IV melanoma patients. , 2010, European journal of cancer.

[86]  Franz Pfeiffer,et al.  Quantitative x-ray dark-field computed tomography , 2010, Physics in medicine and biology.

[87]  J. Willmann,et al.  Molecular ultrasound assessment of tumor angiogenesis , 2010, Angiogenesis.

[88]  V. Ntziachristos,et al.  Molecular imaging by means of multispectral optoacoustic tomography (MSOT). , 2010, Chemical reviews.

[89]  R. Menk,et al.  Microbubbles as x-ray scattering contrast agents using analyzer-based imaging , 2010, Physics in medicine and biology.

[90]  Sanjiv S. Gambhir,et al.  Targeted Contrast-Enhanced Ultrasound Imaging of Tumor Angiogenesis with Contrast Microbubbles Conjugated to Integrin-Binding Knottin Peptides , 2010, Journal of Nuclear Medicine.

[91]  Xiaoyuan Chen,et al.  Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting. , 2009, Biomaterials.

[92]  J. Lee,et al.  First in human evaluation of a newly developed integrin binding PET tracer, 18F-RGD-K5 in patients with breast cancer: Comparison with 18F-FDG uptake pattern and microvessel density , 2009 .

[93]  C. R. Leemans,et al.  124I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of 131I-L19-SIP radioimmunotherapy , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[94]  Jinming Gao,et al.  In vivo off-resonance saturation magnetic resonance imaging of alphavbeta3-targeted superparamagnetic nanoparticles. , 2009, Cancer research.

[95]  R Weissleder,et al.  Molecular imaging. , 2009, Radiology.

[96]  B. Garmy-Susini,et al.  Roles of integrins in tumor angiogenesis and lymphangiogenesis. , 2008, Lymphatic research and biology.

[97]  S. Caruthers,et al.  Three‐dimensional MR mapping of angiogenesis with α5β1(αvβ3)‐targeted theranostic nanoparticles in the MDA‐MB‐435 xenograft mouse model , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[98]  Michael Grasruck,et al.  Flat-panel volume CT: fundamental principles, technology, and applications. , 2008, Radiographics : a review publication of the Radiological Society of North America, Inc.

[99]  Mark Lubberink,et al.  Reproducibility of Tumor Perfusion Measurements Using 15O-Labeled Water and PET , 2008, Journal of Nuclear Medicine.

[100]  Martin A Lodge,et al.  Reproducibility of Tumor Blood Flow Quantification with 15O-Water PET , 2008, Journal of Nuclear Medicine.

[101]  Sanjiv S Gambhir,et al.  Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo. , 2008, Radiology.

[102]  Chenjie Xu,et al.  PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)–Conjugated Radiolabeled Iron Oxide Nanoparticles , 2008, Journal of Nuclear Medicine.

[103]  H. Kessler,et al.  Rational Design of Highly Active and Selective Ligands for the α5β1 Integrin Receptor , 2008, Chembiochem : a European journal of chemical biology.

[104]  Matthias Glaser,et al.  Phase I Trial of the Positron-Emitting Arg-Gly-Asp (RGD) Peptide Radioligand 18F-AH111585 in Breast Cancer Patients , 2008, Journal of Nuclear Medicine.

[105]  O. Bunk,et al.  Hard-X-ray dark-field imaging using a grating interferometer. , 2008, Nature materials.

[106]  Sanjiv S Gambhir,et al.  US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. , 2008, Radiology.

[107]  M. Schwaiger,et al.  Comparison of Integrin αvβ3 Expression and Glucose Metabolism in Primary and Metastatic Lesions in Cancer Patients: A PET Study Using 18F-Galacto-RGD and 18F-FDG , 2007, Journal of Nuclear Medicine.

[108]  Markus Schwaiger,et al.  [18F]Galacto-RGD Positron Emission Tomography for Imaging of αvβ3 Expression on the Neovasculature in Patients with Squamous Cell Carcinoma of the Head and Neck , 2007, Clinical Cancer Research.

[109]  Sanjiv S. Gambhir,et al.  Dual-Function Probe for PET and Near-Infrared Fluorescence Imaging of Tumor Vasculature , 2007, Journal of Nuclear Medicine.

[110]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[111]  Henrik S. Thomsen,et al.  Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents , 2007, Cancer imaging : the official publication of the International Cancer Imaging Society.

[112]  Amir Kashefi,et al.  A new PET tracer specific for vascular endothelial growth factor receptor 2 , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[113]  H. Hollema,et al.  In Vivo VEGF Imaging with Radiolabeled Bevacizumab in a Human Ovarian Tumor Xenograft , 2007, Journal of Nuclear Medicine.

[114]  Tristan Barrett,et al.  MRI of tumor angiogenesis , 2007, Journal of magnetic resonance imaging : JMRI.

[115]  M. Uthappa,et al.  Multidetector CT appearances of splanchnic arterial pathology. , 2007, Clinical radiology.

[116]  E Grabbe,et al.  In vivo imaging in experimental preclinical tumor research–A review , 2007, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[117]  Andrew Needles,et al.  Detecting vascular changes in tumour xenografts using micro-ultrasound and micro-ct following treatment with VEGFR-2 blocking antibodies. , 2007, Ultrasound in medicine & biology.

[118]  M. Welch,et al.  Small-Animal PET of Tumor Angiogenesis Using a 76Br-Labeled Human Recombinant Antibody Fragment to the ED-B Domain of Fibronectin , 2007, Journal of Nuclear Medicine.

[119]  T. Saga,et al.  Chemical design of a radiolabeled gelatinase inhibitor peptide for the imaging of gelatinase activity in tumors. , 2007, Nuclear medicine and biology.

[120]  T. Yankeelov,et al.  Measuring Tumor Perfusion in Control and Treated Murine Tumors , 2007, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[121]  M. Schwaiger,et al.  Comparison of standardised uptake values and distribution volume for imaging of {alpha}v{beta}3 expression in breast cancer patients with [18F]Galacto-RGD PET , 2007 .

[122]  Garry E. Kiefer,et al.  Imaging of Vx‐2 rabbit tumors with ανβ3‐integrin‐targeted 111In nanoparticles , 2007 .

[123]  Marina V Backer,et al.  Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes , 2007, Nature Medicine.

[124]  Emilio Quaia,et al.  Microbubble ultrasound contrast agents: an update , 2007, European Radiology.

[125]  O. Bunk,et al.  Hard x-ray phase tomography with low-brilliance sources. , 2007, Physical review letters.

[126]  Vasilis Ntziachristos,et al.  Tomographic fluorescence imaging of tumor vascular volume in mice. , 2007, Radiology.

[127]  Kai Chen,et al.  Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[128]  Wolfhard Semmler,et al.  Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. , 2007, Cancer research.

[129]  A. Koong,et al.  Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[130]  G. Parker,et al.  DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents , 2007, British Journal of Cancer.

[131]  Rolf A. Brekken,et al.  Monitoring Response to Anticancer Therapy by Targeting Microbubbles to Tumor Vasculature , 2007, Clinical Cancer Research.

[132]  M. Prato,et al.  Carbon nanotubes as nanomedicines: from toxicology to pharmacology. , 2006, Advanced drug delivery reviews.

[133]  R. Nishii,et al.  Radioiodinated VEGF to image tumor angiogenesis in a LS180 tumor xenograft model. , 2006, Nuclear medicine and biology.

[134]  Katherine W Ferrara,et al.  Therapeutic effects of paclitaxel-containing ultrasound contrast agents. , 2006, Ultrasound in medicine & biology.

[135]  Bernard Gallez,et al.  Determination of the maturity and functionality of tumor vasculature by MRI: Correlation between BOLD‐MRI and DCE‐MRI using P792 in experimental fibrosarcoma tumors , 2006, Magnetic resonance in medicine.

[136]  T. Byzova,et al.  Integrin signaling is critical for pathological angiogenesis , 2006, The Journal of experimental medicine.

[137]  H. Vogel,et al.  In Vivo Near-Infrared Fluorescence Imaging of Integrin αvβ3 in an Orthotopic Glioblastoma Model , 2006, Molecular Imaging and Biology.

[138]  L. Dinkelborg,et al.  Imaging of tumor angiogenesis using 99mTc-labeled human recombinant anti-ED-B fibronectin antibody fragments. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[139]  M. Nilsson,et al.  Vascular Endothelial Growth Factor (VEGF) Pathway , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[140]  Takashi Morita,et al.  Molecular and functional diversity of vascular endothelial growth factors , 2006, Molecular Diversity.

[141]  A. Fangberget,et al.  Integrin receptor imaging of breast cancer: a proof-of-concept study to evaluate 99mTc-NC100692. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[142]  Geoff J M Parker,et al.  Comparison of the performance of tracer kinetic model-driven registration for dynamic contrast enhanced MRI using different models of contrast enhancement. , 2006, Academic radiology.

[143]  Weibo Cai,et al.  Anti-Angiogenic Cancer Therapy Based on Integrin αvβ3 Antagonism , 2006 .

[144]  Sharon Bloch,et al.  Targeting Beta-3 integrin using a linear hexapeptide labeled with a near-infrared fluorescent molecular probe. , 2006, Molecular pharmaceutics.

[145]  Philipp Schneider,et al.  Hierarchical microimaging for multiscale analysis of large vascular networks , 2006, NeuroImage.

[146]  Tong San Koh,et al.  Cerebral perfusion mapping using a robust and efficient method for deconvolution analysis of dynamic contrast-enhanced images , 2006, NeuroImage.

[147]  C. Jaffe.  Measures of response: RECIST, WHO, and new alternatives. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[148]  N. Hylton.  Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[149]  Horst Kessler,et al.  Positron Emission Tomography Using [18F]Galacto-RGD Identifies the Level of Integrin αvβ3 Expression in Man , 2006, Clinical Cancer Research.

[150]  Chin-Shang Li,et al.  Angiogenesis inhibitors in a murine neuroblastoma model: quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US. , 2006, Radiology.

[151]  Roland Haubner,et al.  αvβ3-integrin imaging: a new approach to characterise angiogenesis? , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[152]  Ralph Weissleder,et al.  Targeted imaging of human endothelial-specific marker in a model of adoptive cell transfer , 2006, Laboratory Investigation.

[153]  Christopher H. Contag,et al.  In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease , 2006, Nature Reviews Immunology.

[154]  M. Backer,et al.  Self-assembled "dock and lock" system for linking payloads to targeting proteins. , 2006, Bioconjugate chemistry.

[155]  Vimalkumar A. Patel,et al.  In vivo tumor angiogenesis imaging with site-specific labeled 99mTc-HYNIC-VEGF , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[156]  M. Schwaiger,et al.  PET-based human dosimetry of 18F-galacto-RGD, a new radiotracer for imaging alpha v beta3 expression. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[157]  P. Dayton,et al.  Ultrasound assessment of angiogenesis in a matrigel model in rats. , 2006, Ultrasound in medicine & biology.

[158]  Lihong V. Wang,et al.  Photoacoustic imaging in biomedicine , 2006 .

[159]  Sharon Bloch,et al.  Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors. , 2006, Journal of medicinal chemistry.

[160]  O. Bunk,et al.  Phase retrieval and differential phase-contrast imaging with low-brilliance X-ray sources , 2006 .

[161]  A. Jackson,et al.  Comparative study into the robustness of compartmental modeling and model‐free analysis in DCE‐MRI studies , 2006, Journal of magnetic resonance imaging : JMRI.

[162]  Sanjiv S Gambhir,et al.  Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. , 2006, Nano letters.

[163]  P. Sidhu,et al.  New directions in ultrasound: microbubble contrast. , 2006, The British journal of radiology.

[164]  Antony K. Chen,et al.  Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging , 2006, Annals of Biomedical Engineering.

[165]  Kevin Camphausen,et al.  Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[166]  Sanjiv S Gambhir,et al.  Noninvasive indirect imaging of vascular endothelial growth factor gene expression using bioluminescence imaging in living transgenic mice. , 2006, Physiological genomics.

[167]  Hessel Wijkstra,et al.  Ultrasound imaging and contrast agents: A safe alternative to MRI? , 2006, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.

[168]  John D Pickard,et al.  Intersubject Variability and Reproducibility of 15O PET Studies , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[169]  A. Padhani,et al.  Imaging tumour angiogenesis , 2005, Cancer imaging : the official publication of the International Cancer Imaging Society.

[170]  J. Hellinger,et al.  Angiographic imaging of the lower extremities with multidetector CT. , 2005, Radiologic clinics of North America.

[171]  Napoleone Ferrara,et al.  VEGF as a Therapeutic Target in Cancer , 2005, Oncology.

[172]  A. Momose.  Recent Advances in X-ray Phase Imaging , 2005 .

[173]  E Kent Yucel,et al.  MR angiography of aortoiliac occlusive disease: a phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325. , 2005, Radiology.

[174]  K. Claffey,et al.  Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature , 2005, Molecular Cancer Therapeutics.

[175]  Benjamin M Yeh,et al.  Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[176]  Andrea Sbarbati,et al.  Early Antiangiogenic Activity of SU11248 Evaluated In vivo by Dynamic Contrast-Enhanced Magnetic Resonance Imaging in an Experimental Model of Colon Carcinoma , 2005, Clinical Cancer Research.

[177]  Wolfhard Semmler,et al.  Potential applications of flat-panel volumetric CT in morphologic and functional small animal imaging. , 2005, Neoplasia.

[178]  M. Schwaiger,et al.  Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[179]  R. Weissleder,et al.  Tomographic fluorescence mapping of tumor targets. , 2005, Cancer research.

[180]  J. Foidart,et al.  In vitro and in vivo evaluation of [123I]-VEGF165 as a potential tumor marker. , 2005, Nuclear medicine and biology.

[181]  P. Taylor,et al.  Serum vascular markers and vascular imaging in assessment of rheumatoid arthritis disease activity and response to therapy. , 2005, Rheumatology.

[182]  K. Flaherty,et al.  Pharmacodynamic study of BAY 43-9006 in patients with metastatic renal cell carcinoma , 2005 .

[183]  Britton Chance,et al.  Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[184]  A R Padhani,et al.  Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.

[185]  A. Bikfalvi,et al.  Molecular mechanisms of tumor vascularization. , 2005, Critical reviews in oncology/hematology.

[186]  L. Strauss,et al.  Gallium-68-DOTA-albumin as a PET blood-pool marker: experimental evaluation in vivo. , 2005, Nuclear medicine and biology.

[187]  Marco Stampanoni,et al.  The materials science beamline at the Swiss Light Source: design and realization , 2005 .

[188]  S. Griffey,et al.  Contrast-Enhanced Computed Tomography and Ultrasound for the Evaluation of Tumor Blood Flow , 2005, Investigative radiology.

[189]  Grace Hu,et al.  Molecular MR imaging of melanoma angiogenesis with ανβ3‐targeted paramagnetic nanoparticles , 2005, Magnetic resonance in medicine.

[190]  Horst Kessler,et al.  Noninvasive Visualization of the Activated αvβ3 Integrin in Cancer Patients by Positron Emission Tomography and [18F]Galacto-RGD , 2005, PLoS medicine.

[191]  James H Thrall,et al.  Imaging angiogenesis: applications and potential for drug development. , 2005, Journal of the National Cancer Institute.

[192]  K. Balasubramanian,et al.  Chemically functionalized carbon nanotubes. , 2005, Small.

[193]  Gordon C Jayson,et al.  Molecular imaging of antiangiogenic agents. , 2005, The oncologist.

[194]  D. Hicklin,et al.  Elevated Flk1 (Vascular Endothelial Growth Factor Receptor 2) Signaling Mediates Enhanced Angiogenesis in β3-Integrin–Deficient Mice , 2004, Cancer Research.

[195]  R. Moats,et al.  In vivo Near-Infrared Fluorescence Imaging of Integrin αvβ3 in Brain Tumor Xenografts , 2004, Cancer Research.

[196]  Mark Muzi,et al.  18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[197]  Peter S. Conti,et al.  Pegylated Arg-Gly-Asp Peptide: 64Cu Labeling and PET Imaging of Brain Tumor αvβ3-Integrin Expression , 2004 .

[198]  Wolfhard Semmler,et al.  Volumetric computed tomography (VCT): a new technology for noninvasive, high-resolution monitoring of tumor angiogenesis , 2004, Nature Medicine.

[199]  Ryan Park,et al.  MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides. , 2004, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[200]  W. Schima,et al.  Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma. , 2004, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[201]  P. Dayton,et al.  Targeted imaging using ultrasound contrast agents , 2004, IEEE Engineering in Medicine and Biology Magazine.

[202]  Stefanie Mandl,et al.  Tumor imaging using a standardized radiolabeled adapter protein docked to vascular endothelial growth factor. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[203]  P Cloetens,et al.  X‐ray high‐resolution vascular network imaging , 2004, Journal of microscopy.

[204]  J. Provenzale,et al.  A phase I/II trial of single-agent PTK 787/ZK 222584 (PTK/ZK), a novel, oral angiogenesis inhibitor, in patients with recurrent glioblastoma multiforme (GBM). , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[205]  Fergus V Gleeson,et al.  Contrast-enhanced ultrasound assessment of tissue response to high-intensity focused ultrasound. , 2004, Ultrasound in medicine & biology.

[206]  A. Menrad,et al.  Molecular Imaging of Tumor Angiogenesis , 2004, Annals of the New York Academy of Sciences.

[207]  H. Kauczor,et al.  Low Mechanical Index Contrast-Enhanced Ultrasound Better Reflects High Arterial Perfusion of Liver Metastases Than Arterial Phase Computed Tomography , 2004, Investigative radiology.

[208]  M. Schwaiger,et al.  Targeting of gelatinase activity with a radiolabeled cyclic HWGF peptide. , 2004, Nuclear medicine and biology.

[209]  F Forsberg,et al.  Assessment of angiogenesis: implications for ultrasound imaging. , 2004, Ultrasonics.

[210]  Ralph Weissleder,et al.  Seeing Within: Molecular Imaging of the Cardiovascular System , 2004, Circulation research.

[211]  B. Ruggeri,et al.  Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy. , 2004, Current medicinal chemistry.

[212]  R Mark Henkelman,et al.  MicroCT scanner performance and considerations for vascular specimen imaging. , 2004, Medical physics.

[213]  P. Price,et al.  Assessment of inter- and intrapatient variability in C15O2 positron emission tomography measurements of blood flow in patients with intra-abdominal cancers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[214]  W. Webb,et al.  Nonlinear magic: multiphoton microscopy in the biosciences , 2003, Nature Biotechnology.

[215]  P. C. Lin,et al.  Optical imaging and tumor angiogenesis , 2003, Journal of cellular biochemistry.

[216]  G. Hutchins,et al.  Synthesis, biodistribution and micro-PET imaging of a potential cancer biomarker carbon-11 labeled MMP inhibitor (2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [11C]methyl ester. , 2003, Nuclear medicine and biology.

[217]  J. Frangioni.  In vivo near-infrared fluorescence imaging. , 2003, Current opinion in chemical biology.

[218]  A. Kassner,et al.  Molecular Imaging of Angiogenesis in Nascent Vx-2 Rabbit Tumors Using a Novel ανβ3-targeted Nanoparticle and 1.5 Tesla Magnetic Resonance Imaging , 2003 .

[219]  P. Angelberger,et al.  Imaging gastrointestinal tumours using vascular endothelial growth factor-165 (VEGF165) receptor scintigraphy. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[220]  Jonathan R. Lindner,et al.  Imaging Tumor Angiogenesis With Contrast Ultrasound and Microbubbles Targeted to &agr;v&bgr;3 , 2003 .

[221]  William R. Wagner,et al.  Targeted In Vivo Labeling of Receptors for Vascular Endothelial Growth Factor , 2003, Circulation.

[222]  Ding‐Shinn Chen,et al.  Three-dimensional power Doppler ultrasonography for demonstrating associated arteries of hepatocellular carcinoma. , 2003, Journal of the Formosan Medical Association = Taiwan yi zhi.

[223]  W. Webb,et al.  Water-Soluble Quantum Dots for Multiphoton Fluorescence Imaging in Vivo , 2003, Science.

[224]  H. Taniguchi,et al.  The reproducibility of independently measuring human regional hepatic arterial, portal and total hepatic blood flow using [15O]water and positron emission tomography , 2003, Nuclear medicine communications.

[225]  D R Dance,et al.  X-ray refraction effects: application to the imaging of biological tissues. , 2003, The British journal of radiology.

[226]  G. Hutchins,et al.  Synthesis of MMP inhibitor radiotracer [11C]CGS 25966, a new potential pet tumor imaging agent , 2003 .

[227]  S. Gambhir,et al.  Molecular imaging in living subjects: seeing fundamental biological processes in a new light. , 2003, Genes & development.

[228]  Dario Neri,et al.  Immunoscintigraphic detection of the ED-B domain of fibronectin, a marker of angiogenesis, in patients with cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[229]  Hiroshi Fukuda,et al.  Tumor detection using 18F-labeled matrix metalloproteinase-2 inhibitor. , 2003, Nuclear medicine and biology.

[230]  Jamal Zweit,et al.  Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implications for trial design of antiangiogenic antibodies. , 2002, Journal of the National Cancer Institute.

[231]  G. Hutchins,et al.  Synthesis and preliminary biological evaluation of MMP inhibitor radiotracers [11C]methyl-halo-CGS 27023A analogs, new potential PET breast cancer imaging agents. , 2002, Nuclear medicine and biology.

[232]  Timothy J Carroll,et al.  Absolute Quantification of Cerebral Blood Flow with Magnetic Resonance, Reproducibility of the Method, and Comparison with H215O Positron Emission Tomography , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[233]  M. Prokop,et al.  High-resolution CT and CT angiography of peripheral pulmonary vascular disorders. , 2002, Radiographics : a review publication of the Radiological Society of North America, Inc.

[234]  J. Lewin,et al.  A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer. , 2002, Cancer research.

[235]  G. Hutchins,et al.  Synthesis of MMP inhibitor radiotracers [11C]methyl-CGS 27023A and its analogs, new potential PET breast cancer imaging agents , 2002 .

[236]  Erik L Ritman,et al.  The use of microcomputed tomography to study microvasculature in small rodents. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[237]  A. Padhani,et al.  Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysis , 2002, NMR in biomedicine.

[238]  Adam P Dicker,et al.  Comparing contrast-enhanced ultrasound to immunohistochemical markers of angiogenesis in a human melanoma xenograft model: preliminary results. , 2002, Ultrasound in medicine & biology.

[239]  A. Padhani,et al.  Reproducibility of quantitative dynamic MRI of normal human tissues , 2002, NMR in biomedicine.

[240]  Dai Fukumura,et al.  Dissecting tumour pathophysiology using intravital microscopy , 2002, Nature Reviews Cancer.

[241]  S. Aoki,et al.  Quantitative measurement of regional cerebral blood flow with flow-sensitive alternating inversion recovery imaging: comparison with [iodine 123]-iodoamphetamin single photon emission CT. , 2002, AJNR. American journal of neuroradiology.

[242]  David A. Cheresh,et al.  Role of integrins in cell invasion and migration , 2002, Nature Reviews Cancer.

[243]  P. Price,et al.  Clinical measurement of blood flow in tumours using positron emission tomography: a review. , 2002, Nuclear medicine communications.

[244]  A. Janshoff,et al.  Visualization of molecular recognition events on microstructured lipid-membrane compartments by in situ scanning force microscopy. , 2002, Angewandte Chemie.

[245]  Joshua T. Beckham,et al.  In vivo optical imaging of expression of vascular endothelial growth factor following laser incision in skin , 2001, Lasers in surgery and medicine.

[246]  H. Taniguchi,et al.  Reproducibility of repeated human regional splenic blood flow measurements using [15O] water and positron emission tomography , 2001, Nuclear medicine communications.

[247]  R. B. Campbell,et al.  In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy , 2001, Nature Medicine.

[248]  M. O'Doherty,et al.  In vivo evaluation of 111In-DTPA-N-TIMP-2 in Kaposi sarcoma associated with HIV infection , 2001, European Journal of Nuclear Medicine.

[249]  D. Cosgrove,et al.  Microbubble contrast agents: a new era in ultrasound , 2001, BMJ : British Medical Journal.

[250]  M. Dewhirst,et al.  In vivo BOLD contrast MRI mapping of subcutaneous vascular function and maturation: Validation by intravital microscopy , 2001, Magnetic resonance in medicine.

[251]  D. Hallahan,et al.  Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. , 2001, Cancer research.

[252]  Sibylle Ziegler,et al.  Noninvasive Imaging of αvβ3 Integrin Expression Using 18F-labeled RGD-containing Glycopeptide and Positron Emission Tomography , 2001 .

[253]  M. Hidalgo,et al.  Development of matrix metalloproteinase inhibitors in cancer therapy. , 2001, Journal of the National Cancer Institute.

[254]  M Schwaiger,et al.  Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[255]  D M Shames,et al.  MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation. , 2001, Radiology.

[256]  K W Ferrara,et al.  Evaluation of tumor angiogenesis with US: imaging, Doppler, and contrast agents. , 2000, Academic radiology.

[257]  O. Hélénon,et al.  Endorectal color doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findings. , 2000, AJR. American journal of roentgenology.

[258]  M. Dewhirst,et al.  Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models. , 2000, Journal of the National Cancer Institute.

[259]  G. Martiny-Baron,et al.  Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model. , 2000, Cancer research.

[260]  Stasia A. Anderson,et al.  Magnetic resonance contrast enhancement of neovasculature with αvβ3‐targeted nanoparticles , 2000 .

[261]  M. Schaar,et al.  Evaluation of a radiolabelled cyclic DTPA‐RGD analogue for tumour imaging and radionuclide therapy , 2000, International journal of cancer.

[262]  Paul Kinahan,et al.  A combined PET/CT scanner for clinical oncology. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[263]  R V Shohet,et al.  Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. , 2000, Circulation.

[264]  P. Carmeliet.  Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.

[265]  P. Burns,et al.  Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. , 2000, Radiology.

[266]  K. Pienta,et al.  Galectin-3 induces endothelial cell morphogenesis and angiogenesis. , 2000, The American journal of pathology.

[267]  B. Fingleton,et al.  Matrix metalloproteinases: biologic activity and clinical implications. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[268]  S A Tschanz,et al.  Intussusceptive angiogenesis: its role in embryonic vascular network formation. , 2000, Circulation research.

[269]  T. Veikkola,et al.  Regulation of angiogenesis via vascular endothelial growth factor receptors. , 2000, Cancer research.

[270]  J. Calvete,et al.  Structural Requirements of Echistatin for the Recognition of αvβ3 and α5β1Integrins* , 1999, The Journal of Biological Chemistry.

[271]  J. Yap,et al.  Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[272]  D. Ribatti,et al.  The role of the vascular phase in solid tumor growth: a historical review. , 1999, Neoplasia.

[273]  M. Gerritsen,et al.  Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels. , 1999, The American journal of pathology.

[274]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[275]  G. Yancopoulos,et al.  Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. , 1999, Science.

[276]  M. Krasnow,et al.  Genetic control of branching morphogenesis. , 1999, Science.

[277]  Horst Kessler,et al.  Radiolabeled αvβ3 Integrin Antagonists: A New Class of Tracers for Tumor Targeting , 1999 .

[278]  D. Hanahan,et al.  Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. , 1999, Science.

[279]  D. Mooney,et al.  Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. , 1999, The American journal of pathology.

[280]  Ting-Yim Lee,et al.  An Adiabatic Approximation to the Tissue Homogeneity Model for Water Exchange in the Brain: I. Theoretical Derivation , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[281]  R. Hynes,et al.  Extensive Vasculogenesis, Angiogenesis, and Organogenesis Precede Lethality in Mice Lacking All αv Integrins , 1998, Cell.

[282]  S M Jorgensen,et al.  Three-dimensional imaging of vasculature and parenchyma in intact rodent organs with X-ray micro-CT. , 1998, The American journal of physiology.

[283]  Q. Sang,et al.  Complex role of matrix metalloproteinases in angiogenesis , 1998, Cell Research.

[284]  J. Isner,et al.  Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. , 1998, Circulation research.

[285]  J Kettenbach,et al.  Effects of a microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color Doppler US--early experience. , 1998, Radiology.

[286]  F. Miller,et al.  Benign and malignant ovarian masses: selection of the most discriminating gray-scale and Doppler sonographic features. , 1998, Radiology.

[287]  H. Gröne,et al.  Receptors of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney: localization and [125I]VEGF binding sites. , 1998, Journal of the American Society of Nephrology : JASN.

[288]  D C Peters,et al.  Steady-state and dynamic MR angiography with MS-325: initial experience in humans. , 1998, Radiology.

[289]  David A. Cheresh,et al.  Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging , 1998, Nature Medicine.

[290]  Thomas M. Link,et al.  Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media , 1998, Pediatric Radiology.

[291]  Yihai Cao,et al.  Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-γ and migration of endothelial cells expressing Flt 1 , 1998, Oncogene.

[292]  Dario Neri,et al.  Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform , 1997, Nature Biotechnology.

[293]  R. Hynes,et al.  Mesodermal defects and cranial neural crest apoptosis in alpha5 integrin-null embryos. , 1997, Development.

[294]  Horst Kessler,et al.  Stereoisomeric Peptide Libraries and Peptidomimetics for Designing Selective Inhibitors of the αvβ3 Integrin for a New Cancer Therapy , 1997 .

[295]  Thomas N. Sato,et al.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.

[296]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[297]  S. Goodman,et al.  Structural and Functional Aspects of RGD-Containing Cyclic Pentapeptides as Highly Potent and Selective Integrin αVβ3 Antagonists , 1996 .

[298]  B. Keyt,et al.  Identification of Vascular Endothelial Growth Factor Determinants for Binding KDR and FLT-1 Receptors , 1996, The Journal of Biological Chemistry.

[299]  D M Shames,et al.  Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. , 1996, Radiology.

[300]  R. Jain,et al.  Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: a novel mechanism of tumor angiogenesis. , 1996, Microvascular research.

[301]  David A. Cheresh,et al.  Definition of Two Angiogenic Pathways by Distinct αv Integrins , 1995, Science.

[302]  J. Martial,et al.  Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[303]  B. Mazoyer,et al.  Effect of tissue heterogeneity on quantification in positron emission tomography , 1995, European Journal of Nuclear Medicine.

[304]  A K Dixon,et al.  Measurement of human pancreatic perfusion using dynamic computed tomography with perfusion imaging. , 1995, The British journal of radiology.

[305]  D. Cheresh,et al.  Integrin α v β 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels , 1994, Cell.

[306]  D. Cheresh,et al.  Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.

[307]  T. Quinn,et al.  Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[308]  A A Lammertsma,et al.  Low oxygen extraction fraction in tumours measured with the oxygen-15 steady state technique: effect of tissue heterogeneity. , 1992, The British journal of radiology.

[309]  D. Cheresh,et al.  Involvement of integrin alpha V gene expression in human melanoma tumorigenicity. , 1992, The Journal of clinical investigation.

[310]  A A Lammertsma,et al.  Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: a rapid and noninvasive dynamic method. , 1992, Cancer research.

[311]  S. Sugano,et al.  Evaluation of hepatic density change by dynamic CT in healthy humans and in patients with chronic liver diseases , 1992, Digestive Diseases and Sciences.

[312]  L. Orci,et al.  Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. , 1991, Biochemical and biophysical research communications.

[313]  J. T. Littleton,et al.  Pulmonary masses: contrast enhancement. , 1990, Radiology.

[314]  J. Denekamp.  Vascular attack as a therapeutic strategy for cancer , 1990, Cancer and Metastasis Reviews.

[315]  R. Weissleder,et al.  Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. , 1990, Radiology.

[316]  R. Cotran,et al.  Identification of an inducible endothelial-leukocyte adhesion molecule. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[317]  E Ruoslahti,et al.  New perspectives in cell adhesion: RGD and integrins. , 1987, Science.

[318]  N. Nakao,et al.  CT Angiography in Hepatocellular Carcinoma , 1983, Journal of computer assisted tomography.

[319]  B. Zetter,et al.  Migration of capillary endothelial cells is stimulated by tumour-derived factors , 1980, Nature.

[320]  J. Folkman,et al.  Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. , 1977, Microvascular research.

[321]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[322]  Michael M Lell,et al.  Recent and Upcoming Technological Developments in Computed Tomography: High Speed, Low Dose, Deep Learning, Multienergy. , 2019, Investigative radiology.

[323]  H. Wakelee,et al.  Monoclonal Antibodies Targeting Vascular Endothelial Growth Factor , 2012, BioDrugs.

[324]  H. Hollema,et al.  VEGF-PET imaging is a noninvasive biomarker showing differential changes in the tumor during sunitinib treatment. , 2011, Cancer research.

[325]  D. Collins,et al.  Dynamic MRI evaluation of the triple receptor tyrosine kinase inhibitor BIBF 1120 in patients with advanced solid tumours , 2006 .

[326]  René M. Botnar,et al.  Coronary magnetic resonance imaging: visualization of the vessel lumen and the vessel wall and molecular imaging of arteriothrombosis , 2005, European Radiology.

[327]  M. Nguyen.  Angiogenic factors as tumor markers , 2004, Investigational New Drugs.

[328]  M. Schwaiger,et al.  [18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates. , 2004, Bioconjugate chemistry.

[329]  J. Bading,et al.  Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation. , 2004, Nuclear medicine and biology.

[330]  Peter N. Burns,et al.  Ultrasound for the Visualization and Quantification of Tumor Microcirculation , 2004, Cancer and Metastasis Reviews.

[331]  Ryan Park,et al.  MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide. , 2004, Bioconjugate chemistry.

[332]  S. Simon,et al.  Ultrasonic analysis of peptide- and antibody-targeted microbubble contrast agents for molecular imaging of alphavbeta3-expressing cells. , 2004, Molecular imaging.

[333]  J. Suhy,et al.  Imaging in antiangiogenesis trial: a clinical trials radiology perspective. , 2003, The British journal of radiology.

[334]  S. Galbraith,et al.  Antivascular cancer treatments: imaging biomarkers in pharmaceutical drug development. , 2003, The British journal of radiology.

[335]  A. Padhani.  MRI for assessing antivascular cancer treatments. , 2003, The British journal of radiology.

[336]  R. Weissleder.  Scaling down imaging: molecular mapping of cancer in mice , 2002, Nature Reviews Cancer.

[337]  Alexander Petrovsky,et al.  Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. , 2002, Bioconjugate chemistry.

[338]  D. Taverna,et al.  Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins , 2002, Nature Medicine.

[339]  J. M. Harris,et al.  Pegylation: a novel process for modifying pharmacokinetics. , 2001, Clinical pharmacokinetics.

[340]  P. Burns,et al.  Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. , 2000, Investigative radiology.

[341]  Dian Feng,et al.  Heterogeneity of the Angiogenic Response Induced in Different Normal Adult Tissues by Vascular Permeability Factor/Vascular Endothelial Growth Factor , 2000, Laboratory Investigation.

[342]  J. Gamble,et al.  B1 integrin activation inhibits in vitro tube formation: effects on cell migration, vacuole coalescence and lumen formation. , 1999, Endothelium : journal of endothelial cell research.

[343]  P. Tofts.  Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[344]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[345]  H. Birkedal‐Hansen,et al.  Matrix metalloproteinases: a review. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[346]  S. Paku,et al.  First steps of tumor-related angiogenesis. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[347]  M. Moseley,et al.  Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool and perfusion imaging. , 1990, Acta radiologica. Supplementum.